48,830
edits
Line 138: | Line 138: | ||
IHC: | IHC: | ||
*CD2+, CD34+/-, CD56+/-. | *CD2 +ve, CD34 +ve/-ve, CD56 +ve/-ve. | ||
[[Flow cytometry]]: | [[Flow cytometry]]: | ||
*CD34-, HLA-DR-. | *CD34 -ve, HLA-DR -ve. | ||
*CD33+, CD13+/-, CD117+ (weak), CD56+/-. | *CD33 +ve, CD13 +ve/-ve, CD117 +ve (weak), CD56 +ve/-ve. | ||
Clinical: | Clinical: | ||
Line 149: | Line 149: | ||
Variants: | Variants: | ||
*t(11;17) -- ATRA doesn't work. | *t(11;17) -- ATRA doesn't work.<ref>{{Ref APBR|623 Q2}}</ref> | ||
*t(17;17) -- ATRA doesn't work. | *t(17;17) -- ATRA doesn't work. | ||
*t(5;17). (???) | *t(5;17). (???) |
edits